| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
| A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
3 |
| Améliorer la qualité des soins: un aperçu des différentes stratégies |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
77 |
| Barometre des pratiques en medecine liberale Resultats de l'enquete 2006 "L'organisation du travail et la pratique de groupe des medecins generalistes bretons |
0 |
0 |
0 |
12 |
0 |
0 |
11 |
255 |
| Comparative effectiveness research and evidence-based health policy: experience from four countries |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
14 |
| Comparative effectiveness research and evidence-based health policy: experience from four countries |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
15 |
| Competition Between Public and Private Maternity Care Providers in France: Evidence on Market Segmentation |
0 |
0 |
1 |
54 |
0 |
1 |
12 |
113 |
| Competition between Public and Private Maternity Care Providers in France: Evidence on Market Segmentation |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
15 |
| Competition between Public and Private Maternity Care Providers in France: Evidence on Market Segmentation |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
15 |
| Comprative effectiveness research and evidence-Based health policy: Experience from four countries |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
22 |
| Comprative effectiveness research and evidence-Based health policy: Experience from four countries |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
7 |
| Cost-Effectiness of Interventions Based on Physical Activity in the Treatment of Chronic Conditions: A Systematic Literature Review |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
20 |
| Cost-Effectiness of Interventions Based on Physical Activity in the Treatment of Chronic Conditions: A Systematic Literature Review |
0 |
0 |
0 |
1 |
3 |
3 |
7 |
19 |
| Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study |
0 |
0 |
0 |
0 |
0 |
0 |
10 |
10 |
| Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study |
0 |
0 |
0 |
0 |
0 |
2 |
4 |
6 |
| Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
| Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
5 |
| De la mesure de la qualité à son usage dans la régulation des systèmes de santé |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
18 |
| De la mesure de la qualité à son usage dans la régulation des systèmes de santé |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
9 |
| Do Acute Health Shocks Affect Lifestyles? Evidence from the French Gazel Panel Data |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
17 |
| Do Acute Health Shocks Affect Lifestyles? Evidence from the French Gazel Panel Data |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
8 |
| Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
9 |
| Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
4 |
| Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
5 |
| Does the Value per Statistical Life vary with age or baseline health? Evidence from a compensating wage study in France |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
5 |
| Does the Value per Statistical Life vary with age or baseline health? Evidence from a compensating wage study in France |
0 |
0 |
0 |
1 |
0 |
0 |
6 |
8 |
| Drug Price Regulation |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Drug price regulation |
0 |
0 |
0 |
1 |
0 |
0 |
8 |
38 |
| Drug price regulation |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
20 |
| Early Access Schemes and Pricing Strategies: A Case Study on Temporary Authorization for Use in France from 1994 to 2016 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
12 |
| Early Access Schemes and Pricing Strategies: A Case Study on Temporary Authorization for Use in France from 1994 to 2016 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
27 |
| Enjeux de l’évaluation économique de l’activité physique |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
5 |
| Enjeux de l’évaluation économique de l’activité physique |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
| Evaluating the Impact of Intensive Case Management for Severe Vocational Injuries on Work Incapacity and Costs |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
10 |
| Evaluating the Impact of Intensive Case Management for Severe Vocational Injuries on Work Incapacity and Costs |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
| General Considerations on Sports-Related Injuries |
0 |
0 |
0 |
0 |
1 |
1 |
6 |
21 |
| General Considerations on Sports-Related Injuries |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
12 |
| Generating comparative evidence on new drugs and devices before approval |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
14 |
| Generating comparative evidence on new drugs and devices before approval |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
17 |
| HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
9 |
| HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
11 |
| Health Policy: Experience from Four Countries |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
15 |
| Health Policy: Experience from Four Countries |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
| Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
32 |
| Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
13 |
| Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
16 |
| INCERTITUDE; ASYMETRIES INFORMATIONNELLES ET RECHERCHE SUR LE MARCHE DES SERVICES MEDICAUX |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
257 |
| Impact of Diagnosis Related Group Refinement on the Choice Between Scheduled Caesarean Section and Normal Delivery: Recent Evidence from France |
0 |
0 |
0 |
21 |
0 |
0 |
8 |
59 |
| Impact of Diagnosis Related Group Refinement on the Choice Between Scheduled Caesarean Section and Normal Delivery: Recent Evidence from France |
0 |
0 |
0 |
12 |
2 |
2 |
11 |
24 |
| Impact of Quality-Based Procedures on Orthopedic Care Quantity and Quality in Ontario Hospitals |
0 |
0 |
0 |
8 |
0 |
1 |
8 |
40 |
| Impact of Quality-based Procedures on orthopedic care quantity and quality in Ontario Hospitals |
0 |
0 |
0 |
22 |
3 |
3 |
14 |
51 |
| Impact of Quality-based Procedures on orthopedic care quantity and quality in Ontario Hospitals |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
23 |
| Impact of acute health shocks on cigarette consumption: A combined DiD-matching strategy to address endogeneity issues in the French Gazel panel data |
0 |
0 |
0 |
7 |
0 |
1 |
9 |
59 |
| Impact of acute health shocks on cigarette consumption: A combined DiD-matching strategy to address endogeneity issues in the French Gazel panel data |
0 |
0 |
0 |
3 |
0 |
0 |
9 |
30 |
| Impact of tariff refinement on the choice between scheduled C‐section and normal delivery: Evidence from France |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
9 |
| Impact of tariff refinement on the choice between scheduled C‐section and normal delivery: Evidence from France |
0 |
0 |
0 |
9 |
0 |
0 |
2 |
10 |
| Incertitude, asymétries informationnelles et recherche sur le marché des services médicaux |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
57 |
| Inequities in cancer drug development in terms of unmet medical need |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
11 |
| Inequities in cancer drug development in terms of unmet medical need |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
18 |
| Inequities in cancer drug development in terms of unmet medical need |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
25 |
| Into the Far West? Investigating Health Policy-Makers' Willingness to Adopt Decrementally Cost-Effective Innovations Using a DCE Approach |
0 |
0 |
0 |
4 |
1 |
2 |
9 |
27 |
| Into the Far West? Investigating Health Policy-Makers' Willingness to Adopt Decrementally Cost-Effective Innovations Using a DCE Approach |
0 |
0 |
0 |
10 |
0 |
1 |
2 |
8 |
| La Rémunération à la qualité: Praticiens, chercheurs en économie et en gestion |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
8 |
| Les enjeux du calcul économique dans le secteur de la santé |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
28 |
| L’influence des accidents de la route sur les trajectoires professionnelles des personnels en fin de carrière, à partir de la cohorte Gazel |
0 |
0 |
0 |
10 |
1 |
3 |
15 |
91 |
| Multicentre, randomised, economic evaluation of a web-based interactive education platform, simple or enhanced, for patients with end-stage renal disease: the PIC-R trial protocol |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
21 |
| Multicentre, randomised, economic evaluation of a web-based interactive education platform, simple or enhanced, for patients with end-stage renal disease: the PIC-R trial protocol |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
5 |
| Provider Competition in a Dynamic Setting |
0 |
0 |
0 |
97 |
0 |
1 |
11 |
431 |
| Social Capital or Education: What Matters Most to Cut Time to Diagnosis? |
0 |
0 |
0 |
12 |
0 |
0 |
4 |
24 |
| Social Capital or Education: What Matters Most to Cut Time to Diagnosis? |
0 |
0 |
0 |
15 |
0 |
0 |
14 |
61 |
| Social capital and health interventions: enhancing social capital to improve health |
0 |
0 |
0 |
0 |
1 |
1 |
8 |
40 |
| Social capital and health interventions: enhancing social capital to improve health |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
16 |
| The Meliorist Project in health economics |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
3 |
| The Meliorist Project in health economics |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
4 |
| The impact of road accidents on the professional trajectories of staff coming to the end of their careers, based on the Gazel cohort |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
10 |
| The impact of road accidents on the professional trajectories of staff coming to the end of their careers, based on the Gazel cohort |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
13 |
| Économie publique appliquée,: présentation générale |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
4 |
| Évaluation médico-économique de l’éducation thérapeutique par une plateforme interactive communautaire, dialyse et transplantation rénale, PIC-R |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
7 |
| Évaluation médico-économique de l’éducation thérapeutique par une plateforme interactive communautaire, dialyse et transplantation rénale, PIC-R |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
4 |
| Total Working Papers |
1 |
1 |
2 |
303 |
15 |
28 |
466 |
2,447 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
12 |
| Asymétries d'information et incertitude en santé: les apports de la théorie des contrats |
0 |
0 |
2 |
47 |
1 |
2 |
19 |
267 |
| Competition between Public and Private Maternity Care Providers in France: Evidence on Market Segmentation |
0 |
0 |
0 |
2 |
0 |
1 |
15 |
20 |
| Concurrence et assurance santé. Entre vœux pieux et vieux démons |
0 |
0 |
0 |
10 |
0 |
2 |
6 |
38 |
| Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
| Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names |
0 |
0 |
0 |
12 |
1 |
1 |
11 |
52 |
| Does the Value per Statistical Life vary with age or baseline health? Evidence from a compensating wage study in France |
0 |
0 |
0 |
5 |
2 |
4 |
22 |
68 |
| EXIT, CHOICE OR LOYALTY: PATIENT DRIVEN COMPETITION IN PRIMARY CARE |
0 |
0 |
0 |
28 |
0 |
2 |
11 |
151 |
| Financial incentives for physicians: The Quebec experience |
0 |
0 |
1 |
8 |
0 |
0 |
6 |
34 |
| For-profit hospitals for Europe: the case of Britain and France |
0 |
0 |
0 |
29 |
0 |
0 |
5 |
80 |
| Franchise sur les soins ambulatoires et équité sociale |
0 |
0 |
0 |
5 |
1 |
2 |
6 |
55 |
| HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
25 |
| Health care economics: by P. Feldstein John Wiley & Sons, New York, 1988 634 pp., ISBN 0195-3907, [pound sign]21.65 |
0 |
0 |
2 |
88 |
1 |
2 |
6 |
297 |
| Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List |
0 |
0 |
0 |
3 |
0 |
1 |
11 |
28 |
| Impact d’un choc de santé sur les modes de vie, exploitation de la cohorte Gazel |
0 |
0 |
0 |
8 |
0 |
0 |
5 |
29 |
| Impact of tariff refinement on the choice between scheduled C‐section and normal delivery: Evidence from France |
0 |
0 |
0 |
0 |
0 |
2 |
15 |
19 |
| Inequities in cancer drug development in terms of unmet medical need |
0 |
0 |
0 |
1 |
0 |
0 |
5 |
11 |
| Information asymmetry and search in the market for physicians' services |
0 |
0 |
0 |
187 |
0 |
1 |
9 |
394 |
| L'hypothèse de demande induite: un bilan économique |
0 |
0 |
1 |
24 |
0 |
1 |
19 |
404 |
| Le financement par les particuliers: La boîte de Pandore |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
13 |
| Les modes de rémunération des médecins |
0 |
0 |
0 |
9 |
0 |
0 |
5 |
63 |
| Les réformes du service national de santé britannique: la fin d'un mythe ? |
0 |
0 |
0 |
1 |
0 |
0 |
3 |
60 |
| L’influence des accidents de la route sur les trajectoires professionnelles des personnels en fin de carrière, à partir de la cohorte Gazel |
0 |
0 |
0 |
12 |
0 |
2 |
11 |
79 |
| Mesures de l'équité en santé. Fondements éthiques et implications |
0 |
0 |
0 |
23 |
0 |
0 |
10 |
89 |
| Optimal payment schemes for physicians |
0 |
0 |
0 |
2 |
0 |
1 |
9 |
44 |
| Provider Competition in a Dynamic Setting |
0 |
0 |
0 |
19 |
0 |
0 |
7 |
99 |
| Présentation générale |
0 |
0 |
0 |
2 |
0 |
0 |
3 |
18 |
| Présentation générale |
0 |
0 |
0 |
0 |
1 |
1 |
7 |
19 |
| Présentation générale |
0 |
0 |
0 |
0 |
0 |
1 |
7 |
22 |
| Revisiting physicians' financial incentives in Quebec: a panel system approach |
0 |
0 |
1 |
53 |
0 |
0 |
10 |
169 |
| Santé, assurance et équité / Health, Insurance and Equity |
0 |
0 |
1 |
4 |
0 |
1 |
11 |
31 |
| The Meliorist Project in health economics |
0 |
0 |
0 |
2 |
0 |
0 |
8 |
19 |
| Équité dans le financement et la prestation de soins de santé en Europe |
0 |
0 |
0 |
5 |
0 |
0 |
6 |
42 |
| Total Journal Articles |
0 |
0 |
8 |
589 |
7 |
29 |
287 |
2,753 |
LogEc is hosted by the
Örebro University School of Business.